Refresher Course: Cardiac
RC 1503 - Imaging challenging cardiomyopathies
Lectures
1
Chairperson's introduction
05:00Maja Hrabak Paar, Zagreb / HR
2
The added value of dark-blood late gadolinium enhancement
15:00Robert J. Holtackers, Maastricht / NL
3
Arrhythmogenic ventricular cardiomyopathy in the light of the PADUA criteria
15:00Marco Francone, Milan / IT
4
New horizons for imaging cardiomyopathies
15:00Declan O'Regan, London / UK
5
Panel discussion: How to recognise and approach non-ischaemic cardiomyopathies
10:00Panel discussion: How to recognise and approach non-ischaemic cardiomyopathies
5 min
Chairperson's introduction
Maja Hrabak Paar, Zagreb / Croatia
15 min
The added value of dark-blood late gadolinium enhancement
Robert J. Holtackers, Maastricht / Netherlands
1. To distinguish between conventional bright-blood and novel dark-blood LGE techniques.
2. To integrate and apply dark-blood LGE in your daily clinical routine.
3. To select the most appropriate LGE technique given the clinical request.
2. To integrate and apply dark-blood LGE in your daily clinical routine.
3. To select the most appropriate LGE technique given the clinical request.
15 min
Arrhythmogenic ventricular cardiomyopathy in the light of the PADUA criteria
Marco Francone, Milan / Italy
1. To understand the fundamentals of Arrhythmogenic Ventricular Cardiomyopathy (AVC) and its clinical significance, including the associated risk factors and diagnostic challenges.
2. To examine the PADUA criteria, a novel classification system for diagnosing AVC based on CMR findings, and learn how to apply these criteria in clinical practice for an accurate and standardised evaluation.
3. To discuss the clinical implications of using CMR and the PADUA criteria in diagnosing and managing AVC, including their impact on risk stratification, treatment planning, and patient outcomes.
2. To examine the PADUA criteria, a novel classification system for diagnosing AVC based on CMR findings, and learn how to apply these criteria in clinical practice for an accurate and standardised evaluation.
3. To discuss the clinical implications of using CMR and the PADUA criteria in diagnosing and managing AVC, including their impact on risk stratification, treatment planning, and patient outcomes.
15 min
New horizons for imaging cardiomyopathies
Declan O'Regan, London / United Kingdom
1. To understand the principles of CMR image analysis in cardiomyopathy.
2. To appreciate the role of new imaging techniques in diagnosing cardiomyopathy.
3. To learn the future role of AI in assessing cardiomyopathy.
2. To appreciate the role of new imaging techniques in diagnosing cardiomyopathy.
3. To learn the future role of AI in assessing cardiomyopathy.
10 min
Panel discussion: How to recognise and approach non-ischaemic cardiomyopathies